Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:PREFACE
Volume: 17 Issue: 1
Author(s): Emilio Jirillo*
Affiliation:
- Department of Basic Medical Sciences, Neuroscience and Sensory Organs University of Bari, Bari,Italy
Export Options
About this article
Cite this article as:
Jirillo Emilio*, PREFACE, Endocrine, Metabolic & Immune Disorders - Drug Targets 2017; 17 (1) . https://dx.doi.org/10.2174/187153031701170623161132
DOI https://dx.doi.org/10.2174/187153031701170623161132 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Rosuvastatin and Diabetes: When the Evidences Talk
Cardiovascular & Hematological Agents in Medicinal Chemistry Preface : The Mitochondrial Permeability Transition Pore Complex as a Pharmacological Target. An Introduction [Hot topic: Mitochondria as a Target for Apoptosis Modulation (Guest Editor: Guido Kroemer)].
Current Medicinal Chemistry Tissue Biomarkers for Prostate Cancer Radiation Therapy
Current Molecular Medicine Monoclonal Antibodies in Rare Acquired Thrombotic Disorders: The Paradigms of Paroxysmal Nocturnal Hemoglobinuria, Thrombotic Thrombocytopenic Purpura and Central Retinal Vein Occlusion
Current Vascular Pharmacology Why Should Rheumatologists Consider Vitamin D Supplementation for their Patients?
Current Rheumatology Reviews Recent Advances in Nanotechnology-Based Diagnosis and Treatments of Diabetes
Current Drug Metabolism Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
Current Drug Targets Drug Combinations for Dyslipidemia and Obesity Treatment in Metabolic Syndrome
Current Pharmaceutical Design Genetic Studies of Type 2 Diabetes in South Asians: A Systematic Overview
Current Diabetes Reviews Various Cell Therapy Approaches for Bone Diseases in the Controlled Clinical Trials: A Systematic Review and Meta-analysis Study
Current Stem Cell Research & Therapy Understanding the Role of Aldose Reductase in Ocular Inflammation
Current Molecular Medicine An Emerging Strategy for Cancer Treatment Targeting Aberrant Glycogen Synthase Kinase 3β
Anti-Cancer Agents in Medicinal Chemistry Development and Tailoring of Hybrid Lipid Nanocarriers
Current Pharmaceutical Design Reactive Oxygen and Nitrogen Species in the Renal Ischemia/Reperfusion Injury
Current Pharmaceutical Design Nanoembedded Microparticles for Stabilization and Delivery of Drug-Loaded Nanoparticles
Current Pharmaceutical Design Targeting the Role of Astrocytes in the Progression of Alzheimers Disease
Current Signal Transduction Therapy Editorial (Diabetes, Obesity and Vascular Disease - An Update)
Current Pharmaceutical Design Cerebral Amyloidoses: Molecular Pathways and Therapeutic Challenges
Current Medicinal Chemistry Executive Function and Diabetes Mellitus - A Stone Left Unturned?
Current Diabetes Reviews Trefoil Factor Family (TFF) Peptides and their Different Roles in the Mucosal Innate Immune Defense and More: An Update
Current Medicinal Chemistry